For example, a PD-L1-targeting aptamer-ASO chimera effectively suppressed PD-L1 expression in a murine colorectal cancer model, reducing tumor burden to levels comparable to anti-PD-L1 antibody therapy. The gene discussed is CD274; the disease is colorectal cancer.